Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: DASETTA 7/7/7 — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for DASETTA 7/7/7 (norethindrone and ethinyl estradiol) from Northstar Rx LLC, confirming approval of this generic o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DASETTA 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for DASETTA 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)